Concepedia

Y. Shan

YS

3

Publications

126

Citations

3

H-Index

2015

Active since

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Sarah Cannon

City of Hope

Tennessee Oncology

Y. Shan is an author at Roswell Park Comprehensive Cancer Center specializing in cancer research, molecular oncology, and cancer therapeutics.

Top concepts

Publications per year

2015–2024

3

Publications

3

Evaluation of improved γ-aminobutyric acid production in yogurt using Lactobacillus plantarum NDC75017

Y. Shan, Chaoxin Man, Xue Han et al. · Journal of Dairy Science · 2015 · 102 citations · Full text

Efficacy and safety results of FGFR1-3 inhibitor, tinengotinib, as monotherapy in patients with advanced, metastatic cholangiocarcinoma: Results from phase II clinical trial.

Milind Javle, Amit Mahipal, Lionel Aurelien Kankeu Fonkoua et al. · Journal of Clinical Oncology · 2024 · 13 citations

95MO Tinengotinib in patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma

Milind Javle, Lionel Aurelien Kankeu Fonkoua, Amit Mahipal et al. · Annals of Oncology · 2023 · 11 citations · Full text

, , +8

Rows per page

1–3 of 3